FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Dermatol / Bovine papillomaviruses: their role in the aetiology of cuta...
Veterinary dermatology2008; 19(5); 243-254; doi: 10.1111/j.1365-3164.2008.00683.x

Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.

Abstract: Bovine papillomavirus (BPV) is perhaps the most extensively studied animal papillomavirus. In cattle BPVs induce benign tumours of cutaneous or mucosal epithelia, called papillomas or warts. Cattle papillomas are benign tumours and generally regress without eliciting any serious clinical problems in the host, but occasionally persist and provide the focus for malignant transformation to squamous cell carcinoma, as in the case of cancer of the urinary bladder and cancer of the upper alimentary canal. BPV is the only papillomavirus that jumps species: the virus also infects equids, and gives rise to fibroblastic tumours called sarcoids. Sarcoids very rarely regress, more often they persist and can be locally aggressive. These tumours are the most common dermatological tumour of equids worldwide. The purpose of this review is to discuss the biology of BPV, the biology of bovine tumours and equine sarcoids, and present the current understanding of BPV in tumour pathogenesis in its natural host, cattle, and in its heterologous host, equids. Finally, the use of anti-BPV vaccines as a therapy for equine sarcoids will be discussed. Only limited information on the clinical or pathological aspects of either bovine or equine tumours will be provided as this subject has been extensively addressed previously.
Get Full Text
Publication Date: 2008-10-18 PubMed ID: 18927950DOI: 10.1111/j.1365-3164.2008.00683.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on bovine papillomavirus (BPV), a virus extensively studied due to its role in causing benign skin and mucosal tumors, known as papillomas or warts, in animals like cattle and horses. The study further delves into BPV’s ability to affect different species, its role in the malignant transformation of benign tumors, and how potential vaccines against BPV could be used as a treatment for equine sarcoids.

Bovine Papillomavirus (BPV) and its Effect on Cattle

  • The study initially concentrates on the impact of BPV in cattle, wherein it leads to the development of benign tumors, or papillomas, in the skin and in the inner lining of body cavities or mucosal epithelia of the animals.
  • Normally, these benign tumors regress naturally without causing any serious health implications. However, there are cases when BPV becomes a contributing factor for these benign tumors to progress into malignant ones, specifically squamous cell carcinoma.
  • Examples of such progression can be seen in cancers of the urinary bladder and the upper alimentary canal of cattle.

Bovine Papillomavirus (BPV) and its Cross-Species Impact

  • One of the unique features of BPV, as pointed out in the study, is its ability to ‘jump species’. This means BPV also has the capacity to infect equids, or members of the horse family.
  • In equids, BPV results in the formation of fibroblastic tumors known as sarcoids, which differ from the papillomas seen in cattle. These sarcoids typically don’t regress and can sometimes become locally invasive.
  • According to the research, such tumors are the most prevalent dermatological tumors in equids globally.

Role of Vaccines in Treating BPV-Related Tumors

  • The review also touched upon potential treatments for such BPV-related conditions, particularly focusing on the use of anti-BPV vaccines.
  • Such vaccines could potentially be used as a form of therapy for equine sarcoids, offering a promising avenue for future investigations and practical applications.

Although the review does not thoroughly discuss the clinical or pathological aspects of bovine or equine tumors, it acknowledges the extensive previous research in these areas. Its main focus stays on the biology of BPV, its role in inducing tumors in its natural and heterologous hosts, and potential therapeutic interventions using vaccines.

Cite This Article

APA
Nasir L, Campo MS. (2008). Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol, 19(5), 243-254. https://doi.org/10.1111/j.1365-3164.2008.00683.x

Publication

Veterinary dermatology
ISSN: 1365-3164
NlmUniqueID: 9426187
Country: England
Language: English
Volume: 19
Issue: 5
Pages: 243-254

Researcher Affiliations

Nasir, Lubna
  • Division of Pathological Sciences, Institute of Comparative Medicine, University of Glasgow, Garscube Estate, Glasgow G61 1QH. l.nasir@vet.gla.ac.uk
Campo, M Saveria

    MeSH Terms

    • Animals
    • Cattle
    • Cattle Diseases / virology
    • Horse Diseases / virology
    • Horses
    • Papillomaviridae
    • Papillomavirus Infections / etiology
    • Papillomavirus Infections / veterinary
    • Skin Neoplasms / veterinary
    • Skin Neoplasms / virology

    Grant Funding

    • Cancer Research UK
    • Medical Research Council

    Citations

    This article has been cited 69 times.
    1. Frisch V, Fuehrer HP, Cavalleri JV. Relevant Brachycera (Excluding Oestroidea) for Horses in Veterinary Medicine: A Systematic Review. Pathogens 2023 Apr 6;12(4).
      doi: 10.3390/pathogens12040568pubmed: 37111454google scholar: lookup
    2. Hainisch EK, Jindra C, Kirnbauer R, Brandt S. Papillomavirus-like Particles in Equine Medicine. Viruses 2023 Jan 25;15(2).
      doi: 10.3390/v15020345pubmed: 36851559google scholar: lookup
    3. Vasconcelos J, Pires MDA, Alves A, Vieira-Pinto M, Saraiva C, Cardoso L. Neoplasms in Domestic Ruminants and Swine: A Systematic Literature Review. Vet Sci 2023 Feb 18;10(2).
      doi: 10.3390/vetsci10020163pubmed: 36851467google scholar: lookup
    4. Daraban Bocaneti F, Altamura G, Corteggio A, Tanase OI, Dascalu MA, Pasca SA, Hritcu O, Mares M, Borzacchiello G. Expression of collagenases (matrix metalloproteinase-1, -8, -13) and tissue inhibitor of metalloproteinase-3 (TIMP-3) in naturally occurring bovine cutaneous fibropapillomas. Front Vet Sci 2022;9:1072672.
      doi: 10.3389/fvets.2022.1072672pubmed: 36713871google scholar: lookup
    5. Hainisch EK, Jindra C, Reicher P, Miglinci L, Brodesser DM, Brandt S. Bovine Papillomavirus Type 1 or 2 Virion-Infected Primary Fibroblasts Constitute a Near-Natural Equine Sarcoid Model. Viruses 2022 Nov 28;14(12).
      doi: 10.3390/v14122658pubmed: 36560661google scholar: lookup
    6. Cacciotto C, Dore GM, Anfossi AG, Tore G, Varoni MV, Demontis MP, Antuofermo E, Pittau M, Alberti A. Development of immunodiagnostic tools for in situ investigation of Ovis aries papillomavirus 3 (OaPV3). Vet Res Commun 2023 Jun;47(2):641-649.
      doi: 10.1007/s11259-022-10018-5pubmed: 36331789google scholar: lookup
    7. Podstawski P, Samiec M, Skrzyszowska M, Szmatoła T, Semik-Gurgul E, Ropka-Molik K. The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia. Int J Mol Sci 2022 Feb 10;23(4).
      doi: 10.3390/ijms23041970pubmed: 35216085google scholar: lookup
    8. Martano M, Altamura G, Power K, Liguori P, Restucci B, Borzacchiello G, Maiolino P. Beclin 1, LC3 and P62 Expression in Equine Sarcoids. Animals (Basel) 2021 Dec 23;12(1).
      doi: 10.3390/ani12010020pubmed: 35011126google scholar: lookup
    9. Gysens L, Vanmechelen B, Haspeslagh M, Maes P, Martens A. New approach for genomic characterisation of equine sarcoid-derived BPV-1/-2 using nanopore-based sequencing. Virol J 2022 Jan 6;19(1):8.
      doi: 10.1186/s12985-021-01735-5pubmed: 34991633google scholar: lookup
    10. Kattner P, Zeiler K, Herbener VJ, Ferla-Brühl K, Kassubek R, Grunert M, Burster T, Brühl O, Weber AS, Strobel H, Karpel-Massler G, Ott S, Hagedorn A, Tews D, Schulz A, Prasad V, Siegelin MD, Nonnenmacher L, Fischer-Posovszky P, Halatsch ME, Debatin KM, Westhoff MA. What Animal Cancers teach us about Human Biology. Theranostics 2021;11(14):6682-6702.
      doi: 10.7150/thno.56623pubmed: 34093847google scholar: lookup
    11. de Alcântara BK, Lunardi M, Agnol AMD, Alfieri AF, Alfieri AA. Detection and Quantification of the E6 Oncogene in Bovine Papillomavirus Types 2 and 13 From Urinary Bladder Lesions of Cattle. Front Vet Sci 2021;8:673189.
      doi: 10.3389/fvets.2021.673189pubmed: 34055956google scholar: lookup
    12. Gimpelj Domjanič G, Hošnjak L, Lunar MM, Skubic L, Zorec TM, Račnik J, Cigler B, Poljak M. First Report of Phodopus sungorus Papillomavirus Type 1 Infection in Roborovski Hamsters (Phodopus roborovskii). Viruses 2021 Apr 23;13(5).
      doi: 10.3390/v13050739pubmed: 33922632google scholar: lookup
    13. Ata EB, Allam AM, Elbayoumy MK, Mahmoud MAE. Electron microscopy and phylogenetic analysis of Bovine papillomavirus infection in cattle from four Egyptian governorates. Trop Anim Health Prod 2021 Feb 12;53(1):160.
      doi: 10.1007/s11250-021-02607-4pubmed: 33580367google scholar: lookup
    14. Schijns V, Fernández-Tejada A, Barjaktarović Ž, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin Ž, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Slütter B, Thakur A, Christensen D, Lavelle EC. Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunol Rev 2020 Jul;296(1):169-190.
      doi: 10.1111/imr.12889pubmed: 32594569google scholar: lookup
    15. Crisci E, Bárcena J, Montoya M. Virus-like particle-based vaccines for animal viral infections. Inmunologia 2013 Jul-Sep;32(3):102-116.
      doi: 10.1016/j.inmuno.2012.08.002pubmed: 32287712google scholar: lookup
    16. Martano M, Altamura G, Power K, Restucci B, Carella F, Borzacchiello G, Maiolino P. Evaluation of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) in Equine Sarcoid: An Immunohistochemical and Biochemical Study. Pathogens 2020 Jan 14;9(1).
      doi: 10.3390/pathogens9010058pubmed: 31947661google scholar: lookup
    17. Pang F, Chen Z, Wang C, Zhang M, Zhang Z, Yang X, Zheng Y, Liu A, Cheng Y, Chen J, Li B, Du L, Wang F. Comprehensive analysis of differentially expressed microRNAs and mRNAs in MDBK cells expressing bovine papillomavirus E5 oncogene. PeerJ 2019;7:e8098.
      doi: 10.7717/peerj.8098pubmed: 31772843google scholar: lookup
    18. Munday JS, MacLachlan CB, Perrott MR, Aberdein D. Papillomavirus DNA is not Amplifiable from Bladder, Lung, or Mammary Gland Cancers in Dogs or Cats. Animals (Basel) 2019 Sep 8;9(9).
      doi: 10.3390/ani9090668pubmed: 31500370google scholar: lookup
    19. Pang F, Zhang M, Li G, Zhang Z, Huang H, Li B, Wang C, Yang X, Zheng Y, An Q, Zhang L, Du L, Wang F. Integrated mRNA and miRNA profiling in NIH/3T3 cells in response to bovine papillomavirus E6 gene expression. PeerJ 2019;7:e7442.
      doi: 10.7717/peerj.7442pubmed: 31396463google scholar: lookup
    20. Bertagnolli AC, Bezerra AVA, Santos RN, Cavalli LS, Varela APM, Reis EM, Cibulsky SP, Roehe PM, Mayer FQ. Clinicopathological characteristics and papillomavirus types in cutaneous warts in bovine. Braz J Microbiol 2020 Mar;51(1):395-401.
      doi: 10.1007/s42770-019-00121-2pubmed: 31388938google scholar: lookup
    21. Di Bonito P, Galati L, Focà A, Brambilla M, Bisaglia C, Bonanno Ferraro G, Mancini P, Iaconelli M, Veneri C, La Rosa G. Evidence for swine and human papillomavirus in pig slurry in Italy. J Appl Microbiol 2019 Oct;127(4):1246-1254.
      doi: 10.1111/jam.14363pubmed: 31251456google scholar: lookup
    22. Yamashita-Kawanishi N, Tsuzuki M, Wei Z, Kok MK, Ishiyama D, Chambers JK, Uchida K, Dong J, Shimakura H, Haga T. Identification of bovine papillomavirus type 1 and 2 from bovine anogenital fibropapillomas. J Vet Med Sci 2019 Jul 19;81(7):1000-1005.
      doi: 10.1292/jvms.19-0017pubmed: 31155549google scholar: lookup
    23. Willemsen A, Bravo IG. Origin and evolution of papillomavirus (onco)genes and genomes. Philos Trans R Soc Lond B Biol Sci 2019 May 27;374(1773):20180303.
      doi: 10.1098/rstb.2018.0303pubmed: 30955499google scholar: lookup
    24. Martano M, Power K, Restucci B, Pagano I, Altamura G, Borzacchiello G, Maiolino P. Expression of vascular endothelial growth factor (VEGF) in equine sarcoid. BMC Vet Res 2018 Sep 3;14(1):266.
      doi: 10.1186/s12917-018-1576-zpubmed: 30176852google scholar: lookup
    25. Uberoi A, Lambert PF. Rodent Papillomaviruses. Viruses 2017 Nov 27;9(12).
      doi: 10.3390/v9120362pubmed: 29186900google scholar: lookup
    26. Haspeslagh M, Jordana Garcia M, Vlaminck LEM, Martens AM. Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study. BMC Vet Res 2017 Oct 6;13(1):296.
      doi: 10.1186/s12917-017-1215-0pubmed: 28985733google scholar: lookup
    27. Araldi RP, Assaf SMR, Carvalho RF, Carvalho MACR, Souza JM, Magnelli RF, Módolo DG, Roperto FP, Stocco RC, Beçak W. Papillomaviruses: a systematic review. Genet Mol Biol 2017 Jan-Mar;40(1):1-21.
      doi: 10.1590/1678-4685-GMB-2016-0128pubmed: 28212457google scholar: lookup
    28. Martano M, Corteggio A, Restucci B, De Biase ME, Borzacchiello G, Maiolino P. Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study. BMC Vet Res 2016 Feb 2;12:24.
      doi: 10.1186/s12917-016-0648-1pubmed: 26838095google scholar: lookup
    29. Rothacker CC, Boyle AG, Levine DG. Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014). Can Vet J 2015 Jul;56(7):709-14.
      pubmed: 26130832
    30. da Silva FR, Daudt C, Streck AF, Weber MN, Filho RV, Driemeier D, Canal CW. Genetic characterization of Amazonian bovine papillomavirus reveals the existence of four new putative types. Virus Genes 2015 Aug;51(1):77-84.
      doi: 10.1007/s11262-015-1220-ypubmed: 26116287google scholar: lookup
    31. Ewald PW, Swain Ewald HA. Infection and cancer in multicellular organisms. Philos Trans R Soc Lond B Biol Sci 2015 Jul 19;370(1673).
      doi: 10.1098/rstb.2014.0224pubmed: 26056368google scholar: lookup
    32. Bogaert L, Woodham AW, Da Silva DM, Martens A, Meyer E, Kast WM. A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours. J Gen Virol 2015 Sep;96(9):2764-2768.
      doi: 10.1099/vir.0.000212pubmed: 26044793google scholar: lookup
    33. Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Hu J, Christensen ND. A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. PLoS One 2015;10(3):e0120128.
      doi: 10.1371/journal.pone.0120128pubmed: 25803616google scholar: lookup
    34. Bocaneti F, Altamura G, Corteggio A, Velescu E, Borzacchiello G. Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas. Infect Agent Cancer 2015;10(1):2.
      doi: 10.1186/1750-9378-10-2pubmed: 25601891google scholar: lookup
    35. Trewby H, Ayele G, Borzacchiello G, Brandt S, Campo MS, Del Fava C, Marais J, Leonardi L, Vanselow B, Biek R, Nasir L. Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure. J Gen Virol 2014 Dec;95(Pt 12):2748-2756.
      doi: 10.1099/vir.0.066589-0pubmed: 25185436google scholar: lookup
    36. Stocco Rde C, Roperto FP, Nasir L, Sircili MP. Oncogenic processes. Biomed Res Int 2014;2014:879013.
      doi: 10.1155/2014/879013pubmed: 24551854google scholar: lookup
    37. Silva MA, Silva EC, Gurgel AP, Nascimento KC, Freitas AC. Bovine papillomavirus E2 and E5 gene expression in sperm cells of healthy bulls. Virusdisease 2014 Jan;25(1):125-8.
      doi: 10.1007/s13337-013-0185-5pubmed: 24426320google scholar: lookup
    38. García-Pérez R, Ibáñez C, Godínez JM, Aréchiga N, Garin I, Pérez-Suárez G, de Paz O, Juste J, Echevarría JE, Bravo IG. Novel papillomaviruses in free-ranging Iberian bats: no virus-host co-evolution, no strict host specificity, and hints for recombination. Genome Biol Evol 2014 Jan;6(1):94-104.
      doi: 10.1093/gbe/evt211pubmed: 24391150google scholar: lookup
    39. Altamura G, Corteggio A, Nasir L, Yuan ZQ, Roperto F, Borzacchiello G. Analysis of activated platelet-derived growth factor β receptor and Ras-MAP kinase pathway in equine sarcoid fibroblasts. Biomed Res Int 2013;2013:283985.
      doi: 10.1155/2013/283985pubmed: 23936786google scholar: lookup
    40. Mazzuchelli-de-Souza J, Carvalho RF, Ruiz RM, Melo TC, Araldi RP, Carvalho E, Thompson CE, Sircili MP, Beçak W, Stocco RC. Expression and in Silico analysis of the recombinant bovine papillomavirus E6 protein as a model for viral oncoproteins studies. Biomed Res Int 2013;2013:421398.
      doi: 10.1155/2013/421398pubmed: 23878806google scholar: lookup
    41. Cotugno R, Gallotta D, d'Avenia M, Corteggio A, Altamura G, Roperto F, Belisario MA, Borzacchiello G. BAG3 protects bovine papillomavirus type 1-transformed equine fibroblasts against pro-death signals. Vet Res 2013 Jul 22;44(1):61.
      doi: 10.1186/1297-9716-44-61pubmed: 23876161google scholar: lookup
    42. Carvalho RF, Sakata ST, Giovanni DN, Mori E, Brandão PE, Richtzenhain LJ, Pozzi CR, Arcaro JR, Miranda MS, Mazzuchelli-de-Souza J, Melo TC, Comenale G, Assaf SL, Beçak W, Stocco RC. Bovine papillomavirus in Brazil: detection of coinfection of unusual types by a PCR-RFLP method. Biomed Res Int 2013;2013:270898.
      doi: 10.1155/2013/270898pubmed: 23865043google scholar: lookup
    43. Borzacchiello G. Bovine papillomavirus on the scene of crime: is E5 oncogene the only guilty party?. Infect Agent Cancer 2013 Jul 5;8(1):26.
      doi: 10.1186/1750-9378-8-26pubmed: 23829702google scholar: lookup
    44. Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Travé G. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 2013 Feb 8;339(6120):694-8.
      doi: 10.1126/science.1229934pubmed: 23393263google scholar: lookup
    45. Corteggio A, Altamura G, Roperto F, Borzacchiello G. Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?. Infect Agent Cancer 2013 Jan 9;8(1):1.
      doi: 10.1186/1750-9378-8-1pubmed: 23302179google scholar: lookup
    46. Finlay M, Yuan Z, Morgan IM, Campo MS, Nasir L. Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53. Vet Res 2012 Dec 4;43(1):81.
      doi: 10.1186/1297-9716-43-81pubmed: 23210796google scholar: lookup
    47. Altamura G, Strazzullo M, Corteggio A, Francioso R, Roperto F, D'Esposito M, Borzacchiello G. O(6)-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis. BMC Vet Res 2012 Nov 10;8:218.
      doi: 10.1186/1746-6148-8-218pubmed: 23140380google scholar: lookup
    48. Love AJ, Chapman SN, Matic S, Noris E, Lomonossoff GP, Taliansky M. In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta 2012 Oct;236(4):1305-13.
      doi: 10.1007/s00425-012-1692-0pubmed: 22718313google scholar: lookup
    49. Crisci E, Bárcena J, Montoya M. Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol 2012 Aug 15;148(3-4):211-25.
      doi: 10.1016/j.vetimm.2012.04.026pubmed: 22705417google scholar: lookup
    50. Strazzullo M, Corteggio A, Altamura G, Francioso R, Roperto F, D'Esposito M, Borzacchiello G. Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids. BMC Vet Res 2012 Mar 16;8:30.
      doi: 10.1186/1746-6148-8-30pubmed: 22424615google scholar: lookup
    51. Jagu S, Malandro N, Kwak K, Yuan H, Schlegel R, Palmer KE, Huh WK, Campo MS, Roden RB. A multimeric L2 vaccine for prevention of animal papillomavirus infections. Virology 2011 Nov 10;420(1):43-50.
      doi: 10.1016/j.virol.2011.07.020pubmed: 21920572google scholar: lookup
    52. Hainisch EK, Brandt S, Shafti-Keramat S, Van den Hoven R, Kirnbauer R. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses. Equine Vet J 2012 Jan;44(1):107-11.
      doi: 10.1111/j.2042-3306.2011.00390.xpubmed: 21895749google scholar: lookup
    53. Sidi AO, Babah KO, Brimer N, Nominé Y, Romier C, Kieffer B, Pol SV, Travé G, Zanier K. Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6. Protein Expr Purif 2011 Nov;80(1):8-16.
      doi: 10.1016/j.pep.2011.06.013pubmed: 21777678google scholar: lookup
    54. Hartl B, Hainisch EK, Shafti-Keramat S, Kirnbauer R, Corteggio A, Borzacchiello G, Tober R, Kainzbauer C, Pratscher B, Brandt S. Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation. J Gen Virol 2011 Oct;92(Pt 10):2437-2445.
      doi: 10.1099/vir.0.033670-0pubmed: 21715602google scholar: lookup
    55. Wobeser BK, Davies JL, Hill JE, Jackson ML, Kidney BA, Mayer MN, Townsend HG, Allen AL. Epidemiology of equine sarcoids in horses in western Canada. Can Vet J 2010 Oct;51(10):1103-8.
      pubmed: 21197201
    56. Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt S, Kirnbauer R. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. Virology 2009 Oct 10;393(1):1-6.
      doi: 10.1016/j.virol.2009.07.036pubmed: 19729180google scholar: lookup
    57. Abousamra E, Jagt B, Osafo E, Rochman ND. Harmonized nonhuman cancer database. bioRxiv 2025 Oct 20;.
      doi: 10.1101/2025.10.19.683290pubmed: 41473316google scholar: lookup
    58. Szczerba-Turek A. Can Oncogenic Animal Viruses Pose a Threat to Humans?. Pathogens 2025 Nov 14;14(11).
      doi: 10.3390/pathogens14111163pubmed: 41305399google scholar: lookup
    59. Ibrahim AH, El-Habbaa AS, El-Nahas EM. Virological perspectives of the current situation of oncogenic viruses in Egypt: a review. Infect Agent Cancer 2025 Nov 14;20(1):82.
      doi: 10.1186/s13027-025-00706-7pubmed: 41233817google scholar: lookup
    60. Cutarelli A, Buonavoglia A, Fusco G, Pellicanò R, Napoletano M, Brandt S, Roperto S. Accurate identification of bovine deltapapillomavirus in equine sarcoids by ddPCR. Sci Rep 2025 Aug 11;15(1):29414.
      doi: 10.1038/s41598-025-15353-6pubmed: 40790360google scholar: lookup
    61. Liu Y, Xie L, Zhou Y, Zhou L, Bi J, Zheng M, Lan T, Sun W. Human papillomavirus in canine serum: evidence from a Chinese study. Front Vet Sci 2025;12:1511289.
      doi: 10.3389/fvets.2025.1511289pubmed: 40370836google scholar: lookup
    62. Vychodilova L, Plasil M, Futas J, Kopecka A, Molinkova D, Wijacki T, Jahn P, Knoll A, Horin P. Genetic susceptibility to sarcoid in Arabian horses: associations with MHC class II and compound MHC class I/KLRA genotypes. Vet Res Commun 2025 May 1;49(3):184.
      doi: 10.1007/s11259-025-10748-2pubmed: 40310488google scholar: lookup
    63. De Falco F, Cutarelli A, Pellicanò R, Brandt S, Roperto S. Molecular Detection and Quantification of Ovine Papillomavirus DNA in Equine Sarcoid. Transbound Emerg Dis 2024;2024:6453158.
      doi: 10.1155/2024/6453158pubmed: 40303025google scholar: lookup
    64. Quatember H, Nell B, Richter B, Rigler D, Dolezal M, Sykora S, Wallner B. Studying the Impact of the DDB2 T338M Missense Mutation on the Development of Equine Squamous Cell Carcinoma and Sarcoid. Animals (Basel) 2025 Mar 22;15(7).
      doi: 10.3390/ani15070911pubmed: 40218305google scholar: lookup
    65. Medeiros-Fonseca B, Faustino-Rocha AI, Pires MJ, Neuparth MJ, Vala H, Vasconcelos-Nóbrega C, Gouvinhas I, Barros AN, Dias MI, Barros L, Bastos MMSM, Gonçalves L, Félix L, Venâncio C, Medeiros R, da Costa RMG, Oliveira PA. Exploring the therapeutic potential of Quercus ilex acorn extract in papillomavirus-induced lesions. Vet World 2024 Nov;17(11):2644-2658.
      doi: 10.14202/vetworld.2024.2644-2658pubmed: 39829663google scholar: lookup
    66. de Camargo LJ, Alves RS, Dos Santos RN, Baumbach LF, Olegário JDC, Rabaioli V, Silva MO, Witt AA, Godinho FM, Salvato RS, Weber MN, da Silva MS, Daudt C, Budaszewski RDF, Canal CW. Characterization of Three Novel Papillomavirus Genomes in Vampire Bats (Desmodus rotundus). Animals (Basel) 2024 Dec 14;14(24).
      doi: 10.3390/ani14243604pubmed: 39765508google scholar: lookup
    67. Iamborwornkun N, Kitkumthorn N, Stevenson A, Kirk A, Graham SV, Chuen-Im T. Identifying regulatory elements and their RNA-binding proteins in the 3' untranslated regions of papillomavirus late mRNAs. Biomed Rep 2024 Aug;21(2):125.
      doi: 10.3892/br.2024.1813pubmed: 39006509google scholar: lookup
    68. Beermann A, Clottu O, Reif M, Biegel U, Unger L, Koch C. A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. J Vet Intern Med 2024 May-Jun;38(3):1815-1824.
      doi: 10.1111/jvim.17052pubmed: 38529853google scholar: lookup
    69. Pyrek P, Bednarski M, Popiel J, Siedlecka M, Karwańska M. Genetic Evaluation of Bovine Papillomavirus Types Associated with Teat Papillomatosis in Polish Dairy Cattle with the Report of a New Putative Type. Pathogens 2023 Oct 25;12(11).
      doi: 10.3390/pathogens12111278pubmed: 38003743google scholar: lookup
    Subscribe to our newsletter
    Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.